News

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Moderna expects to have mNEXSPIKE available for eligible populations in the U.S. for the 2025-2026 respiratory virus season, alongside Spikevax and mRESVIA ®, the Company's approved respiratory ...
What Are The New NB.1.8.1 COVID Variant Symptoms And When Will It Hit The U.S.? Doctors Explain
A new COVID variant is spreading quite quickly and is under monitoring by the WHO. The new is variant called NB.1.8.1 and is in the same family as Omicron. Here's what to look out for and potential ...